Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: Peptide-induced T-cell immunity

Journal of the National Cancer Institute

Volumn 93, Issue 23, 2001, Pages 1775-1783

  Hanabuchi, S ^a   Ohashi, T ^a   Koya, Y ^a   Kato, H ^a   Hasegawa, A ^a   Takemura, F ^a   Masuda, T ^a   Kannagi, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARAGINE; CANCER VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GLYCINE; LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHENYLALANINE; PROLINE; SYNTHETIC PEPTIDE; TAX PROTEIN; THREONINE; TYROSINE; VALINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER REGRESSION; CELL SPECIFICITY; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; DRUG EFFECT; EPITOPE MAPPING; FEMALE; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INOCULATION; LYMPHOCYTE CULTURE; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR RECOGNITION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SPLEEN LYMPHOCYTE; T CELL LYMPHOMA; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR VOLUME;

EID: 0035814451     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.23.1775     Document Type: Article

References (45)

1. Adult T-cell leukemia: Clinical and hematologic features of 16 cases
2. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
3. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
4. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis
5. HTLV-I associated myelopathy, a new clinical entity
6. HTLV-I oncoprotein tax and cellular transcription factors
7. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro
8. Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1
9. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocyte culture
10. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells
11. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus
12. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient
13. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
14. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis
15. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells
16. + cytotoxic T cells directed against HTLV-I-infected cells
17. Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells
18. Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade
19. Specificity pockets for the side chains of peptide antigens in HLA-Aw68
20. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens
21. DNA vaccines: Immunology, application, and optimization*
22. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
23. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
24. Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax
25. Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization
26. 1
27. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T-cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine
28. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection
29. Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease
30. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing
31. 51Cr-labelled allogenic target cells in vitro; Inhibition by isoantibody and by drugs
32. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells
33. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
34. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease
35. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides
36. + T cell responses in antitumor immunity
37. CD4 T cells and their role in antitumor immune responses
38. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15
39. Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus
40. CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95)
41. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1
42. Design and evaluation of antigen-specific vaccination strategies against cancer
43. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule
44. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously
45. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): Impairment of T-cell control of Epstein-Barr virus-infected B-cells